linde plc - LIN

LIN

Close Chg Chg %
498.19 5.81 1.17%

Closed Market

504.00

+5.81 (1.17%)

Volume: 2.76M

Last Updated:

Feb 24, 2026, 4:00 PM EDT

Company Overview: linde plc - LIN

LIN Key Data

Open

$497.86

Day Range

494.57 - 504.49

52 Week Range

387.78 - 500.57

Market Cap

$232.63B

Shares Outstanding

466.95M

Public Float

464.51M

Beta

0.84

Rev. Per Employee

N/A

P/E Ratio

34.10

EPS

$14.68

Yield

120.44%

Dividend

$1.50

EX-DIVIDEND DATE

Dec 3, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

2.83M

 

LIN Performance

1 Week
 
3.57%
 
1 Month
 
10.32%
 
3 Months
 
20.70%
 
1 Year
 
8.78%
 
5 Years
 
103.95%
 

LIN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 30
Full Ratings ➔

About linde plc - LIN

Linde Plc is a global industrial gases and engineering company. It designs and builds equipment that produces industrial gases. The company also offers gas production and processing services such as olefin plants, natural gas plants, air separation plants, hydrogen and synthesis gas plants and other types of plants. Its primary products are atmospheric gases and process gases. The company operates through the following reportable segments: Americas, EMEA APAC and Engineering. The Americas segment operates production facilities primarily in the United Sates, Canada, Mexico and Brazil. The EMEA segment has production facilities primarily in Germany, France, Sweden, the Republic of South Africa, and the United Kingdom. The APAC segment has production facilities located primarily in China, Australia, India, South Korea and Thailand. The Engineering segment designs and constructs turnkey process plants for third-party customers as well as for the gases businesses in many locations worldwide. Linde was founded by Carl Paul Gottfried von Lind in 1879 and is headquartered in Woking, the United Kingdom.

LIN At a Glance

Linde Plc
Forge
Woking, Surrey GU21 6HT
Phone 44-1483-242-200 Revenue 33.99B
Industry Chemicals: Specialty Net Income 6.90B
Sector Process Industries 2025 Sales Growth 2.972%
Fiscal Year-end 12 / 2026 Employees N/A
View SEC Filings

LIN Valuation

P/E Current 33.984
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 29.185
Price to Sales Ratio 5.924
Price to Book Ratio N/A
Price to Cash Flow Ratio 19.50
Enterprise Value to EBITDA 17.267
Enterprise Value to Sales 6.614
Total Debt to Enterprise Value 0.12

LIN Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 6.492
Total Asset Turnover 0.407

LIN Liquidity

Current Ratio 0.877
Quick Ratio 0.742
Cash Ratio 0.333

LIN Profitability

Gross Margin 37.763
Operating Margin 27.229
Pretax Margin 26.178
Net Margin 20.297
Return on Assets 8.263
Return on Equity 18.072
Return on Total Capital 10.574
Return on Invested Capital 12.196

LIN Capital Structure

Total Debt to Total Equity 70.569
Total Debt to Total Capital 41.373
Total Debt to Total Assets 31.087
Long-Term Debt to Equity 54.08
Long-Term Debt to Total Capital 31.706
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Linde Plc - LIN

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
33.36B 32.85B 33.01B 33.99B
Sales Growth
+8.35% -1.53% +0.46% +2.97%
Cost of Goods Sold (COGS) incl D&A
23.65B 21.31B 20.92B 21.15B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.20B 3.82B 3.78B 3.76B
Depreciation
- 3.63B 3.27B 3.23B
Amortization of Intangibles
- 571.00M 550.00M 554.00M
COGS Growth
+6.66% -9.92% -1.81% +1.09%
Gross Income
9.71B 11.55B 12.08B 12.83B
Gross Income Growth
+12.71% +18.91% +4.64% +6.22%
Gross Profit Margin
+29.10% +35.14% +36.61% +37.76%
2022 2023 2024 2025 5-year trend
SG&A Expense
3.25B 3.44B 3.49B 3.58B
Research & Development
143.00M 146.00M 150.00M 147.00M
Other SG&A
3.11B 3.29B 3.34B 3.43B
SGA Growth
-2.46% +5.88% +1.34% +2.67%
Other Operating Expense
- - - -
-
Unusual Expense
1.02B (38.00M) 73.00M 273.00M
EBIT after Unusual Expense
5.44B 8.14B 8.52B 8.98B
Non Operating Income/Expense
297.00M 333.00M 619.00M 171.00M
Non-Operating Interest Income
- 117.00M 197.00M 228.00M
Equity in Earnings of Affiliates
- 18.00M 2.00M 3.00M
Interest Expense
192.00M 488.00M 572.00M 255.00M
Interest Expense Growth
+20.75% +154.17% +17.21% -55.42%
Gross Interest Expense
254.00M 555.00M 640.00M 255.00M
Interest Capitalized
- 62.00M 67.00M 68.00M
Pretax Income
5.54B 7.99B 8.57B 8.90B
Pretax Income Growth
+8.71% +44.11% +7.27% +3.83%
Pretax Margin
+16.61% +24.31% +25.96% +26.18%
Income Tax
1.43B 1.81B 2.00B 1.99B
Income Tax - Current - Domestic
- 578.00M 407.00M 610.00M
Income Tax - Current - Foreign
- 1.24B 1.49B 1.53B
Income Tax - Deferred - Domestic
- (5.00M) 62.00M 14.00M
Income Tax - Deferred - Foreign
- (378.00M) (146.00M) (156.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- 18.00M 2.00M 3.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
4.28B 6.34B 6.74B 7.06B
Minority Interest Expense
134.00M 142.00M 172.00M 160.00M
Net Income
4.15B 6.20B 6.57B 6.90B
Net Income Growth
+8.53% +49.48% +5.90% +5.07%
Net Margin Growth
+12.43% +18.87% +19.89% +20.30%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
4.15B 6.20B 6.57B 6.90B
Preferred Dividends
- - - -
-
Net Income Available to Common
4.15B 6.20B 6.57B 6.90B
EPS (Basic)
8.2984 12.6979 13.7121 14.6926
EPS (Basic) Growth
+12.11% +53.02% +7.99% +7.15%
Basic Shares Outstanding
499.74M 488.19M 478.77M 469.49M
EPS (Diluted)
8.2276 12.5922 13.6177 14.61
EPS (Diluted) Growth
+12.23% +53.05% +8.14% +7.29%
Diluted Shares Outstanding
504.04M 492.29M 482.09M 472.19M
EBITDA
10.66B 11.92B 12.38B 13.02B
EBITDA Growth
+7.52% +11.79% +3.81% +5.19%
EBITDA Margin
+31.96% +36.28% +37.49% +38.30%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 514.87
Number of Ratings 30 Current Quarters Estimate 4.266
FY Report Date 03 / 2026 Current Year's Estimate 17.836
Last Quarter’s Earnings 4.20 Median PE on CY Estimate N/A
Year Ago Earnings 16.46 Next Fiscal Year Estimate 19.484
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 19 18 26 22
Mean Estimate 4.27 4.45 17.84 19.48
High Estimates 4.32 4.55 18.05 20.40
Low Estimate 4.18 4.35 17.60 18.45
Coefficient of Variance 0.78 1.21 0.60 2.27

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 20 20 20
OVERWEIGHT 1 5 3
HOLD 8 6 5
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Linde Plc - LIN

Date Name Shares Transaction Value
Jan 22, 2026 Stephen F. Angel Director 462,791 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 22, 2026 Stephen F. Angel Director 460,239 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $440.04 per share 202,523,569.56
Jan 22, 2026 Stephen F. Angel Director 102,579 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 20, 2025 Thomas Enders Director 10,595 Bona fide gift 0.00
May 21, 2025 David P. Strauss Executive VP, Chief HR Officer 22,639 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $457.04 per share 10,346,928.56
Mar 12, 2025 Matthew J. White Chief Financial Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Robert L. Wood Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Robert L. Wood Director 14,463 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $468.77 per share 6,779,820.51
Mar 12, 2025 Paula Rosput Reynolds Director 464 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Paula Rosput Reynolds Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Paula Rosput Reynolds Director 716 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Matthew J. White Chief Financial Officer 19,156 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Matthew J. White Chief Financial Officer 2,728 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Matthew J. White Chief Financial Officer 4,784 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Matthew J. White Chief Financial Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Sean Durbin Executive VP, North America 10,889 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 12, 2025 Matthew J. White Chief Financial Officer 75,650 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $468.77 per share 35,462,450.50
Mar 12, 2025 Matthew J. White Chief Financial Officer 77,867 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2025 Matthew J. White Chief Financial Officer 73,083 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $468.77 per share 34,259,117.91
Mar 12, 2025 Matthew J. White Chief Financial Officer 76,697 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Linde Plc in the News